4.3 Article

Adipose-derived stem cell exosomes for treatment of dupilumab-related facial redness in patients with atopic dermatitis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Dermatology

Human mesenchymal stem cell-derived exosomes accelerate wound healing of mice eczema

Miao Wang et al.

Summary: The therapeutic effect of Mesenchymal stem cell-derived exosomes (MSC-exs) on eczema mice model was investigated in this study. The results showed that MSC-ex treatment accelerated wound healing in the eczema mouse model by reducing scar formation, inhibiting inflammatory cell infiltration, and promoting vascular formation.

JOURNAL OF DERMATOLOGICAL TREATMENT (2022)

Article Biochemistry & Molecular Biology

Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Psoriasis-like Skin Inflammation

Yuli Zhang et al.

Summary: MSC-derived exosomes have regulatory effects on psoriasis-like skin inflammation by suppressing epidermal proliferation, reducing inflammation index, decreasing the expression of inflammatory factors, and inhibiting the maturation and activation of immune cells.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2022)

Article Dermatology

Exosomes derived from human adipose tissue-derived mesenchymal stem cells for the treatment of dupilumab-related facial redness in patients with atopic dermatitis: A report of two cases

Kui Young Park et al.

Summary: This study investigated the topical application of human adipose tissue-derived mesenchymal stem cell-derived exosomes for reducing dupilumab facial redness in patients with severe atopic dermatitis. Results showed a marked improvement in erythematous facial lesions after six sessions of treatment. Further controlled studies with a larger number of patients are necessary to confirm the efficacy and safety of this potential treatment option.

JOURNAL OF COSMETIC DERMATOLOGY (2022)

Article Dermatology

Elevation of peripheral blood eosinophils during dupilumab treatment for atopic dermatitis is associated with baseline comorbidities and development of facial redness dermatitis and ocular surface disease

Silvia Ferrucci et al.

Summary: Transient eosinophilia is common in patients with moderate-to-severe atopic dermatitis treated with dupilumab. Patients with a history of conjunctivitis, food allergies, facial redness dermatitis, or dupilumab-induced ocular surface disease experience significant increases in absolute eosinophil count at 4 months.

JOURNAL OF DERMATOLOGICAL TREATMENT (2022)

Article Dermatology

Facial erythema in patients with atopic dermatitis treated with Dupilumab - a descriptive study of morphology and Aetiology

J. Ahn et al.

Summary: This study described the clinical features, morphology, and causes of facial dermatitis in patients treated with dupilumab for atopic dermatitis. The majority of patients experienced improvement in their facial dermatitis with dupilumab therapy, but a small proportion of patients had new onset or exacerbation.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)

Review Chemistry, Medicinal

Extracellular Vesicles in Skin Wound Healing

Deimante Narauskaite et al.

Summary: Extracellular vesicles (EVs) play a crucial role in wound healing and potential therapeutic interventions. In addition to their natural healing capacity, EVs can be engineered to carry specific cargo for targeted pharmaceutical purposes, making them a promising treatment modality.

PHARMACEUTICALS (2021)

Review Dermatology

Facial and neck erythema associated with dupilumab treatment: A systematic review

Christine E. Jo et al.

Summary: This study summarized 101 cases of dupilumab-associated facial or neck erythema, with some patients showing symptoms from baseline atopic dermatitis while others possibly having different etiologies. Treatment strategies included topical corticosteroids and other medications, with patients showing varying degrees of improvement or worsening in symptoms.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)

Article Chemistry, Multidisciplinary

Sequential Release of Small Extracellular Vesicles from Bilayered Thiolated Alginate/Polyethylene Glycol Diacrylate Hydrogels for Scarless Wound Healing

Yifan Shen et al.

Summary: The study developed bilayered thiolated alginate/PEG diacrylate (BSSPD) hydrogels for sequential release of different types of sEVs to promote wound healing. The results showed that phased release of sEVs can achieve scarless wound healing more quickly and effectively.

ACS NANO (2021)

Review Immunology

IL-1 Family Antagonists in Mouse and Human Skin Inflammation

Praxedis Martin et al.

Summary: IL-1 family cytokines play important roles in skin disorders, and dysregulated signaling may lead to the development of chronic inflammatory diseases. Anti-inflammatory IL-1 family members such as IL-1Ra and IL-36Ra control the biological activity of pro-inflammatory IL-1 family agonists. These cytokines are highly expressed in the epidermis and have therapeutic potential for human inflammatory skin diseases.

FRONTIERS IN IMMUNOLOGY (2021)

Review Medicine, Research & Experimental

A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine

Soudeh Moghadasi et al.

Summary: The exosomes derived from MSCs are potential nanocarriers for diagnosis and therapy, transferring functional molecules to target cells to promote tissue repair in various human disorders. Compared to MSCs, MSC-exosomes are more stable and have reduced safety risks, making them a promising cell-free therapeutic strategy in regenerative medicine.

JOURNAL OF TRANSLATIONAL MEDICINE (2021)

Review Medicine, General & Internal

New Treatments for Atopic Dermatitis Targeting Skin Barrier Repair via the Regulation of FLG Expression

Anna Debinska

Summary: Atopic dermatitis is a common chronic, inflammatory skin disorder with a complex etiology and diverse clinical manifestations. Skin barrier dysfunction and immunological abnormalities play critical roles in its pathogenesis. New therapeutic approaches targeting specific pathophysiological pathways are being developed, emphasizing the regulation of skin barrier-related molecules.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Biochemistry & Molecular Biology

Extracellular Vesicles from Korean Codium fragile and Sargassum fusiforme Negatively Regulate Melanin Synthesis

Bohee Jang et al.

Summary: This study found that extracellular vesicles from Codium fragile and Sargassum fusiforme effectively reduce melanin synthesis and may serve as potential therapeutic and whitening agents.

MOLECULES AND CELLS (2021)

Review Dermatology

Research Advances in the Application of Adipose-Derived Stem Cells Derived Exosomes in Cutaneous Wound Healing

Zeng Weiliang et al.

Summary: Adipose-derived stem cells (ADSCs) are becoming increasingly popular in the field of cutaneous wound healing, exerting influences by releasing paracrine signaling factors or differentiating into mature adipose cells to promote wound healing.

ANNALS OF DERMATOLOGY (2021)

Review Dermatology

Therapeutic New Era for Atopic Dermatitis: Part 1. Biologics

Jiyoung Ahn et al.

Summary: Atopic dermatitis is a chronic, inflammatory cutaneous disease caused by immune dysregulation and skin barrier dysfunction. Recent advances in understanding the pathogenesis of AD have led to innovation in therapeutics, with different immune pathways playing a role in the complex AD pathophysiology. Newer, safer, and more effective treatments are needed to control the extreme clinical heterogeneity and chronic progression of AD.

ANNALS OF DERMATOLOGY (2021)

Review Dermatology

Facial and neck erythema associated with dupilumab treatment: A review

Christine E. Jo et al.

Summary: In this study, a total of 101 patients with dupilumab-associated facial or neck erythema were analyzed. Different etiologies, including rosacea and allergic contact dermatitis, were suggested. Prompt identification and treatment may help alleviate distress and prevent discontinuation of dupilumab.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)

Letter Allergy

Facial Redness in Atopic Dermatitis Patients Treated With Dupilumab: A Case Series

Seung Hui Seok et al.

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2020)

Review Immunology

Emerging Topical and Systemic JAK Inhibitors in Dermatology

Farzan Solimani et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Biochemistry & Molecular Biology

VEGF Upregulation in Viral Infections and Its Possible Therapeutic Implications

Khaled R. Alkharsah

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Cell & Tissue Engineering

Exosomes derived from human adipose tissue-derived mesenchymal stem cells alleviate atopic dermatitis

Byong Seung Cho et al.

STEM CELL RESEARCH & THERAPY (2018)

Article Biochemistry & Molecular Biology

Exosomes Derived from Human Endothelial Progenitor Cells Accelerate Cutaneous Wound Healing by Promoting Angiogenesis Through Erk1/2 Signaling

Jieyuan Zhang et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)

Article Medicine, General & Internal

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

E. L. Simpson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Cell & Tissue Engineering

HucMSC-Exosome Mediated-Wnt4 Signaling Is Required for Cutaneous Wound Healing

Bin Zhang et al.

STEM CELLS (2015)

Article Cell & Tissue Engineering

Mesenchymal Stem Cells Secrete Immunologically Active Exosomes

Bin Zhang et al.

STEM CELLS AND DEVELOPMENT (2014)

Article Biochemistry & Molecular Biology

The Epithelial Cell-Derived Atopic Dermatitis Cytokine TSLP Activates Neurons to Induce Itch

Sarah R. Wilson et al.

Article Allergy

Thymic stromal lymphopoietin and allergic disease

Steven F. Ziegler

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)

Article Multidisciplinary Sciences

Differential release of chromatin-bound IL-1α discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation

Idan Cohen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Review Medicine, General & Internal

Wound healing and its impairment in the diabetic foot

V Falanga

LANCET (2005)